 |
 | ||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
| ||||||||
 |
| ||||||||||
 |
| ||||||||||
|
|
| ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||||
|
|
| ||||||||||
|
|
| ||||||||||
| deNovo Biologic is dedicated to the development of novel bioproducts through the harnessing of cellular evolution in the laboratory. Our approach to discovery focuses on developing laboratory methods that mimic interactions between mammalian eukaryotic cells and the stressful environments to which they are exposed in the natural world. To date, our research has produced a novel oxygen environment-driven bioprocess that evolves novel "humanized" bacteria from human eukaryotic cells within days to weeks of bioprocess initiation. This laboratory breakthrough establishes a precedent for laboratory-controlled saltatory evolutionary emergence and the use of laboratory-controlled emergent evolution in the generation of novel cellular bioproducts. | |
| Expanding its interests in the areas of cellular evolution and development, deNovo Biologic has discovered unique patterns of tertiary self-organization in the Gram-positive eubacterium Staphylococcus epidermidis that mimic patterns of tertiary self-organization observed in multicellular eukaryotic tissues. deNovo Biologic is actively collaborating with other laboratories to research and understand the potential biological, biomedical, and biotechnological implications of this novel multicellular eukaryotic-like "tissue" development in bacteria. | |
| We invite you to browse our web site. Learn more about deNovo Biologic's novel bioprocess for the emergent evolution of novel bacteria and its promise for a new generation of bioproducts, and find the latest news on deNovo Biologic's research on "tissue" development in bacteria. | |